Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an ongoing global health threat. However, currently, no standard therapy has been approved for the disease. OBJECTIVES: To evaluate the clinical effectiveness of convalescent plasma (CP) in patients with acute respiratory distress syndrome (ARDS) du...

Descripción completa

Detalles Bibliográficos
Autores principales: Eren, Esma, Ulu-Kılıç, Ayşegül, Korkmaz, Serdal, Yıldız, Merve, Yüksel, Recep Civan, Kılınç-Toker, Ayşin, Arman-Fırat, Emine, Bestepe-Dursun, Zehra, Çelik, Ilhami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623836/
https://www.ncbi.nlm.nih.gov/pubmed/34468633
http://dx.doi.org/10.1590/1516-3180.2021.0200.R1.03052021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623836/
https://www.ncbi.nlm.nih.gov/pubmed/34468633
http://dx.doi.org/10.1590/1516-3180.2021.0200.R1.03052021

Ejemplares similares